Home NDC 59651-801 ROFLUMILAST
Product NDC 59651-801
11-digit product format 596510801
Labeler code 59651
Product ID 59651-801_586e58c7-172f-4c3f-a91f-045ea4d089fc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ROFLUMILAST
Dosage form TABLET
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA213298
Marketing category ANDA
Marketing start 2025-01-31
Substance ROFLUMILAST
Active strength 250 ug/1
Pharmacologic classes Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213298-001 ROFLUMILAST ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 A213298-002 ROFLUMILAST ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 3f0d92c62455…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213298-001 ROFLUMILAST 500MCG TABLET / ORAL AB 2023-04-17 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213298-002 ROFLUMILAST 250MCG TABLET / ORAL AB 2025-01-31 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base ROFLUMILAST
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ROFLUMILAST 250 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0P6C6ZOP5U Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1091839 Internal RxNorm lookup 2001319 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59651-801-20 ROFLUMILAST 1 in 1 CARTON TABLET 1 6 59651-801-20 ROFLUMILAST 20 in 1 BLISTER PACK TABLET 20 6 59651-801-28 ROFLUMILAST 28 in 1 BLISTER PACK TABLET 28 6 59651-801-28 ROFLUMILAST 1 in 1 CARTON TABLET 1 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59651-801 ROFLUMILAST TABLET [AUROBINDO PHARMA LIMITED] 6 Current NDC, 4 package rows 20250529_7cb11d48-6bb9-437b-bc7f-382050a2d3e6.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 59651-801-20 59651080120 1 BLISTER PACK in 1 CARTON (59651-801-20) / 20 TABLET in 1 BLISTER PACK 1 blister pack 2025-01-31 No No Current 59651-801-28 59651080128 1 BLISTER PACK in 1 CARTON (59651-801-28) / 28 TABLET in 1 BLISTER PACK 1 blister pack 2025-01-31 No No Current